This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
The problem, Zaaijer explained, is that algorithms used in precision medicine models overwhelming are built on DNA with ...
Kickstart your UPSC Prelims prep early—begin with current affairs for a strong foundation. Brush up your current affairs ...
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
MEMORANDUM FOR THE SECRETARY OF HEALTH AND HUMAN SERVICES THE DIRECTOR OF THE CENTERS FOR DISEASE CONTROL AND PREVENTION SUBJECT: Aligning United ...
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $500.0 and $750.0 for Regeneron Pharmaceuticals, spanning the ...
Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
8d
Lyme disease often goes undetected when it's most treatable. These teens are working to change that.
Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...
The Functional Genomics Screening Laboratory, based at the Milner Therapeutics Institute, has won an OBN Award in the ...
TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...
These stocks have market caps of around $4 billion and $5 billion, and they could potentially double or triple in size in the long run.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback